Analysis of Mortality Trends for Cerebrovascular Disease in Colombia from 2010 to 2021
Abstract
Introduction: globally, cerebrovascular disease is the second leading cause of death and the third leading cause of disability.
Objective: To discuss the narratives of Colombian health system stakeholders regarding care for people with cerebrovascular disease (CVD) in relation to the analysis of CVD mortality trends in Colombia between 2010 and 2021, by sex.
Methods: A mixed-method approach with an exploratory sequential design was used, combining qualitative data from focus groups with health system stakeholders and an ecological trend analysis study. CVD mortality data from the National Department of Statistics (DANE) were used, and Joinpoint regression was applied to assess changes.
Results: Stakeholders indicated that health outcomes and their analysis are essential for guiding care. Mortality, as a conclusive outcome, reflects the impact of the disease, and understanding it can contribute to its prevention. A sustained increase in CVD mortality was observed between 2010 and 2014, with higher rates among men. Between 2015 and 2021, a significant reduction was observed nationally and among women. Throughout the period, deaths from CVD primarily affected people over 50 years of age, with a higher concentration among those over 80.
Conclusions: The contrast between the qualitative and quantitative findings suggests that the increase in mortality rates between 2020 and 2021 requires a deeper understanding of the factors that influence their variability. It also highlights the importance of legitimizing the experiences and needs of system stakeholders when formulating health care strategies.
Downloads
-
Abstract468
-
ESP_PDF (Español (España))202
-
ENG_PDF140
-
XML (Español (España))0
References
Alonso E, Fernández LC, Tejedor ED. Enfermedades cerebrovasculares. Medicine. 2023; 13(70): 4073–82. doi: https://doi.org/10.1016/j.med.2023.01.001
Muñoz-Collazos M. Enfermedades cerebrovasculares (ECV). Acta Neurol Colomb. 2010;26(2): 59-61. Available from: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-87482010000200002&lng=en
Johansson A, Drake I, Engström G, Acosta S. Modifiable and Non-Modifiable Risk Factors for Atherothrombotic Ischemic Stroke among Subjects in the Malmö Diet and Cancer Study. Nutrients. 2021;13(6):1952.
Bender del Busto JE. Las enfermedades cerebrovasculares como problema de salud. Rev Cubana Neurol Neurocir. 2019; 9(2). Available from: https://revneuro.sld.cu/index.php/neu/article/view/335
Guerrero Agámez D, Pestaña Utria G, Diaz Arrieta B, Vargas Moranth R, Alvis Guzmán N. Mortalidad por enfermedades cerebrovasculars en Colombia: 30 años de observación. Acta Neurológica Colombiana. 2021;37(4):173–88. doi: https://doi.org/10.22379/24224022386
Abootalebi S, Aertker BM, Andalibi MS, Asdaghi N, Aykac O, Azarpazhooh MR, et al. Call to action: SARS-CoV-2 and cerebrovascular disorders (CASCADE). Journal of Stroke and Cerebrovascular Diseases. 2020;29(9):104938.
Lv B, Song G, Jing F, et al. Mortality from cerebrovascular diseases in China: Exploration of recent and future trends. Chin Med J (Engl). 2024; 137(5): 588-595. https://doi.org/10.1097/CM9.0000000000002760
Soto Á, Guillén-Grima F, Morales G, Muñoz S, Aguinaga-Ontoso I, Vanegas J. Trends in Mortality from Stroke in Latin America and the Caribbean, 1979-2015. Glob Heart. 2022;17(1):26.
Instituto Nacional de Salud, Observatorio Nacional de Salud. Cuando la muerte es evitable. 2023. [cited 2025 Feb 01]. Available from: https://www.ins.gov.co/Direcciones/ONS/Informes/15.%20Cuando%20la%20muerte%20es%20evitable.pdf
Ministerio de Salud y Protección Social. Plan Decenal de Salud Pública 2022-2031. 2022 [cited 2025 Feb 01]. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/documento-plan-decenal-salud-publica-2022-2031.pdf
Theunissen L, Cremers HP, Dekker L, Janssen H, Burg M, Huijbers E, Voermans P, Kemps H, van Veghel D. Implementing Value-Based Health Care Principles in the Full Cycle of Care: The Pragmatic Evolution of the Netherlands Heart Network. Circ Cardiovasc Qual Outcomes. 2023 Apr;16(4):e009054. doi:10.1161/CIRCOUTCOMES.122.009054
Creswell JW. Research design: qualitative, quantitative, and mixed methods approaches. 3. ed., [Nachdr.]. Los Angeles: SAGE Publ; 2009. 260
Strauss A, Corbin J. Bases de la investigación cualitativa: técnicas y procedimientos para desarrollar la teoría fundamentada. Medellín: Universidad de Antioquia; 2016.
Morgenstern H. Ecologic studies in epidemiology: concepts, principles, and methods. Annu Rev Public Health. 1995; 16:61-81. doi:10.1146/annurev.pu.16.050195.000425
DANE. Defunciones No Fetales. 2010 [cited 2025 Feb 01]. Available from: https://www.dane.gov.co/index.php/estadisticas-por-tema/salud/nacimientos-y-defunciones/defunciones-no-fetales/defunciones-no-fetales-2010
Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Geneva: World Health Organization. 2001.
Organización Panamericana de la Salud. La Estandarización OMS. Un método epidemiológico clásico para la comparación de tasas. Boletín epidemiológico. 2002;23(3).
Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates [published correction appears in Stat Med 2001 Feb 28;20(4):655]. Stat Med. 2000;19(3):335-351. doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z
National Cancer Institute. Joinpoint. 2022 [cited 2025 Feb 01]. Available from: https://surveillance.cancer.gov/help/joinpoint/
Vidal C, Hoffmeister L, Biagini L. Tendencia de la mortalidad por cáncer de cuello uterino en Chile: aplicación de modelos de regresión joinpoint [Trend in cervical cancer mortality in Chile: application of joinpoint regression models]. Rev Panam Salud Publica. 2013;33(6):407-413.
Alharbi AA, Almalki MHM, Alhawit ME, Alharbi AM, Almutairi GT, Alhejaili OLO, et al. The impact of value-based care models: The role of nurses and administrators in healthcare improvement. Int J Health Sci. el 15 de enero de 2022;6(S10):2186–211
Hospital Internacional de Colombia. ¿Quiénes somos? Centro de Excelencia en Ataque Cerebrovascular [Internet]. Piedecuesta: Hospital Internacional de Colombia; [cited 2025 Mar 20]. Disponible en: https://hic.fcv.org/co/instituto-neurologico/servicios/centro-de-excelencia-en-ataque-cerebrovascular-primario/quienes-somos
McKevitt C, Redfern J, Mold F, Wolfe C. Qualitative studies of stroke: a systematic review. Stroke. 2004;35(6):1499-1505. doi:10.1161/01.STR.0000127532.64840.36
Hwai SWC, Wardlaw JM, Williams A, Doubal FN. What matters to people and families affected by cerebral small vessel disease (SVD)? A qualitative grounded theory investigation. Cereb Circ Cogn Behav. 2024;6:100202. doi:10.1016/j.cccb.2024.100202
Instituto Nacional de Salud, Asi vamos en salud.org. Tasa de Mortalidad por Enfermedades Cerebrovasculares – Georeferenciado. 2024 [cited 2025 Feb 01]. Available from: https://www.asivamosensalud.org/indicadores/enfermedades-cronicas-no-transmisibles/tasa-de-mortalidad-por-enfermedades
Bayona H. Trombólisis cerebral en Colombia un llamado a la excelencia. Acta Neurológica Colombiana. 2022;38(3):111–2.
López-Jaramillo P, Anthony Camacho P. Un reto para Colombia: mejorar la utilización de medicamentos probadamente beneficiosos en la prevención secundaria cardiovascular. Colombia Médica. 2012;43(1):7–10.
World Heart Federation. Deaths from cardiovascular disease surged 60% globally over the last 30 years: Report. 2023 [cited 2025 Feb 01]. Available from: https://world-heart-federation.org/news/deaths-from-cardiovascular-disease-surged-60-globally-over-the-last-30-years-report/
Ministerio de Salud y protección Social M. Normograma en salud. 2016. Resolución 3202 de 2016. 2016 [cited 2025 Feb 01]. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/resolucion-3202-de-2016.pdd
Ministerio de Salud y Protección Social M. Repositorio Institucional Digital. 2023 [cited 2025 Feb 01] Lineamientos para la gestión de las enfermedades cardiovasculares y metabólicas. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/lineamientos-gestion-enfermedades-cardiovasculares-metabolicas.pdf
Arrivillaga M. Assesing Health Services in Colombia: Development of a Conceptual Framework and Measurement tools based on primary data. SAGE Open. 2021;11(2):21582440211016844.
Feigin VL, Brainin M, Norrving B, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022 [published correction appears in Int J Stroke. 2022 Apr;17(4):478. doi: 10.1177/17474930221080343.]. Int J Stroke. 2022;17(1):18-29. doi:10.1177/17474930211065917
Contreras JP, Pérez O, Figueroa N. Enfermedad cerebrovascular en mujeres: estado del arte y visión del cardiólogo. Rev Colomb Cardiol. 2018;25:113–9.
Hanna M, Wabnitz A, Grewal P. Sex and stroke risk factors: A review of differences and impact. Journal of Stroke and Cerebrovascular Diseases. 2024;33(4):107624.
Saad M, Saleem M, Maqbool U, et al. Trends in cerebrovascular disease-related mortality among older adults in the United States from 1999 to 2020: An analysis of gender, race/ethnicity, and geographical disparities. J Stroke Cerebrovasc Dis. 2025;34(1):108043. doi:10.1016/j.jstrokecerebrovasdis.2024.108043
Cayuela A, Cayuela L, Escudero-Martínez I, Rodríguez-Domínguez S, González A, Moniche F, et al. Análisis de las tendencias en la mortalidad por enfermedades cerebrovasculares en España 1980-2011. Neurología. 2016;31(6):370–8.
Dávila CA. Tendencia e impacto de la mortalidad por enfermedades cardiovasculares en México, 1990-2015. Rev cub salud pública. 2020;45: e1081.
Kapral MK, Austin PC, Jeyakumar G, et al. Rural-Urban Differences in Stroke Risk Factors, Incidence, and Mortality in People With and Without Prior Stroke. Circ Cardiovasc Qual Outcomes. 2019;12(2): e004973. doi:10.1161/CIRCOUTCOMES.118.004973
Organización Mundial de la Salud O. Enfermedades cardiovasculares. 2021 [cited 2024 Sept 26]. Available from: https://www.who.int/es/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
Martin SS, Aday AW, Almarzooq ZI, et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association [published correction appears in Circulation. 2024 May 7;149(19):e1164. doi: 10.1161/CIR.0000000000001247.]. Circulation. 2024;149(8):e347-e913. doi:10.1161/CIR.0000000000001209
Organizacional O. The Global Health Observatory. 2024 [cited 2024 Sept 26]. Noncommunicable diseases: Mortality. Disponible en: https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/ncd-mortality
Feigin VL, Martins SC, Brainin M, Norrving B, Kamenova S, Giniyat A, et al. Twenty years on from the introduction of the high risk strategy for stroke and cardiovascular disease prevention: a systematic scoping review. European Journal of Neurology. 2024;31(3):e16157.
Nuño-Solinís R. Advancing Towards Value-Based Integrated Care for Individuals and Populations. Int J Integr Care. 2019 Dec 4;19(4):8.
Copyright (c) 2025 Global Nursing
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The works published in this magazine are subject to the following terms:
1. The Publications Service of the University of Murcia (the publisher) preserves the copyright of the published works, and encourages and allows the reuse of the works under the license for use stated in point 2.
© Servicio de Publicaciones, Universidad de Murcia, 2011 (© Publications Service, University of Murcia, 2011)
2. The works are published in the electronic edition of the journal under Creative Commons Reconocimiento-NoComercial-SinObraDerivada 3.0 España(texto legal) “ a Attribution-NonCommercial-NoDerivatives 3.0 Spain license (legal text)”. They can be copied, used, broadcasted, transmitted and publicly displayed, provided that: i) the authorship and original source of their publication (journal, publisher and URL) are cited; (ii) are not used for commercial purposes; iii) the existence and specifications of this license is mentioned.
3. Conditions of self-archiving. Authors are allowed and encouraged to electronically disseminate the pre-print (pre-reviewed ) and / or post-print (reviewed and accepted for publication) versions of their works prior to publication, as it ensures a wider circulation and dissemination which may lead to a possible increase in its mention and a higher scope among the academic community. RoMEO color: green.
